B-cell Acute Lymphocytic Leukemia
3 clinical trials · Condition
◉ Watch B-cell Acute Lymphocytic Leukemia
| Record | Firm | Date |
|---|---|---|
| Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab (NCT06287229) | M.D. Anderson Cancer Center | 2024-07-11 |
| CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL. (NCT03263208) | Henan Cancer Hospital | 2017-08-16 |
| CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia (NCT03064269) | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 2017-03-01 |
Track B-cell Acute Lymphocytic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.